News Pharma attacks plan to ration new drugs in England Plans to ration and delay use of novel drugs in England have been condemned by the pharma industry and a health charity.
News Tax breaks could nurture UK’s cell and gene therapy manufact... Tax breaks for R&D and innovative manufacturing could be part of life sciences strategy.
News Norgine rejoins ABPI after eight year absence ABPI says Norgine's support will be important during Brexit.
News Invest in NHS to boost life sciences, says pharma body Make NHS best place to research and launch drugs, says ABPI.
News UK will leave single market, pharma highlighted as key indus... May sets out plans to leave single market, and aim for EU free trade deal
Events Partner Content Making Pharmaceuticals Europe 13th-14th March 2018 New European exhibition launch for pharma industry
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
